Tag : Extends


Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results

Treatment with evinacumab safely reduced LDL cholesterol levels in patients with treatment-refractory hypercholesterolemia in a multicenter, phase 2 study of 272 patients treated for 16...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy